# Newton Golf Company, Inc.: financial statements, quarterly

NWTG · Nasdaq · CIK 1934245 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nwtg.md) · [Financials](/companies/nwtg/financials.md) · [Filings](/companies/nwtg/filings.md) · [Insiders](/companies/nwtg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nwtg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [95.0](/filings/0001493152-24-045401.md) | [117 d](/filings/0001641172-25-002840.md) | [350](/filings/0001641172-25-010572.md) | [813](/filings/0001641172-25-023708.md) | [1,211](/filings/0001493152-25-022293.md) | [1,071 d](/filings/0001493152-26-014164.md) | [1,210](/filings/0001493152-26-023127.md) | [2,068](/filings/0001493152-26-038399.md) | [2,582](/filings/0001493152-25-022293.md) | [2,275 d](/filings/0001493152-26-014164.md) | [991](/filings/0001493152-26-023127.md) | [1,316](/filings/0001493152-26-038399.md) |
| Cost of revenue | $k | [56.0](/filings/0001493152-24-045401.md) | [93.0 d](/filings/0001641172-25-002840.md) | [144](/filings/0001641172-25-010572.md) | [324](/filings/0001641172-25-023708.md) | [406](/filings/0001493152-25-022293.md) | [297 d](/filings/0001493152-26-014164.md) | [358](/filings/0001493152-26-023127.md) | [669](/filings/0001493152-26-038399.md) | [848](/filings/0001493152-25-022293.md) | [1,706 d](/filings/0001493152-26-014164.md) | [363](/filings/0001493152-26-023127.md) | [405](/filings/0001493152-26-038399.md) |
| Gross profit | $k | [39.0](/filings/0001493152-24-045401.md) | [24.0 d](/filings/0001641172-25-002840.md) | [206](/filings/0001641172-25-010572.md) | [489](/filings/0001641172-25-023708.md) | [805](/filings/0001493152-25-022293.md) | [774 d](/filings/0001493152-26-014164.md) | [852](/filings/0001493152-26-023127.md) | [1,399](/filings/0001493152-26-038399.md) | [1,734](/filings/0001493152-25-022293.md) | [569 d](/filings/0001493152-26-014164.md) | [628](/filings/0001493152-26-023127.md) | [911](/filings/0001493152-26-038399.md) |
| Research and development | $k | [15.0](/filings/0001493152-24-045401.md) | [200 d](/filings/0001641172-25-002840.md) | [190](/filings/0001641172-25-010572.md) | [207](/filings/0001641172-25-023708.md) | [201](/filings/0001493152-25-022293.md) | [145 d](/filings/0001493152-26-014164.md) | [282](/filings/0001493152-26-023127.md) | [143](/filings/0001493152-26-038399.md) | [182](/filings/0001493152-25-022293.md) | [172 d](/filings/0001493152-26-014164.md) | [348](/filings/0001493152-26-023127.md) | [348](/filings/0001493152-26-038399.md) |
| Selling, general and administrative | $k | [1,195](/filings/0001493152-24-045401.md) | [1,739 d](/filings/0001641172-25-002840.md) | [1,271](/filings/0001641172-25-010572.md) | [1,484](/filings/0001641172-25-023708.md) | [1,694](/filings/0001493152-25-022293.md) | [2,060 d](/filings/0001493152-26-014164.md) | [2,541](/filings/0001493152-26-023127.md) | [2,763](/filings/0001493152-26-038399.md) | [3,056](/filings/0001493152-25-022293.md) | [2,963 d](/filings/0001493152-26-014164.md) | [2,895](/filings/0001493152-26-023127.md) | [2,103](/filings/0001493152-26-038399.md) |
| Operating income | $k | [(1,171)](/filings/0001493152-24-045401.md) | [(1,915) d](/filings/0001641172-25-002840.md) | [(1,255)](/filings/0001641172-25-010572.md) | [(1,202)](/filings/0001641172-25-023708.md) | [(1,090)](/filings/0001493152-25-022293.md) | [(1,431) d](/filings/0001493152-26-014164.md) | [(1,971)](/filings/0001493152-26-023127.md) | [(1,507)](/filings/0001493152-26-038399.md) | [(1,504)](/filings/0001493152-25-022293.md) | [(2,566) d](/filings/0001493152-26-014164.md) | [(2,615)](/filings/0001493152-26-023127.md) | [(1,540)](/filings/0001493152-26-038399.md) |
| Interest expense | $k | [26.0](/filings/0001493152-23-040376.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,197)](/filings/0001493152-24-045401.md) | [(1,839) d](/filings/0001641172-25-002840.md) | [(1,193)](/filings/0001641172-25-010572.md) | [(1,155)](/filings/0001641172-25-023708.md) | [(1,060)](/filings/0001493152-25-022293.md) | [(8,344) d](/filings/0001493152-26-014164.md) | [(525)](/filings/0001493152-26-023127.md) | [(1,520)](/filings/0001493152-26-038399.md) | [(1,580)](/filings/0001493152-25-022293.md) | [(2,395) d](/filings/0001493152-26-014164.md) | [(2,659)](/filings/0001493152-26-023127.md) | [(2,278)](/filings/0001493152-26-038399.md) |
| Diluted EPS | $ per share | [(0.94)](/filings/0001493152-24-045401.md) | not reported | [(24.52)](/filings/0001641172-25-010572.md) | [(0.79)](/filings/0001641172-25-023708.md) | [(21.79)](/filings/0001493152-25-022293.md) | not reported | [(0.55)](/filings/0001493152-26-023127.md) | [(0.34)](/filings/0001493152-26-038399.md) | [(0.34)](/filings/0001493152-25-022293.md) | not reported | [(0.58)](/filings/0001493152-26-023127.md) | [(0.49)](/filings/0001493152-26-038399.md) |
| Basic EPS | $ per share | [(0.94)](/filings/0001493152-24-045401.md) | not reported | [(24.52)](/filings/0001641172-25-010572.md) | [(0.79)](/filings/0001641172-25-023708.md) | [(21.79)](/filings/0001493152-25-022293.md) | not reported | [(0.55)](/filings/0001493152-26-023127.md) | [(0.34)](/filings/0001493152-26-038399.md) | [(0.34)](/filings/0001493152-25-022293.md) | not reported | [(0.58)](/filings/0001493152-26-023127.md) | [(0.49)](/filings/0001493152-26-038399.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.8](/filings/0001493152-23-040376.md) | [5.3](/filings/0001641172-25-002840.md) | [4.1](/filings/0001493152-24-017176.md) | [2.8](/filings/0001493152-24-030203.md) | [1.3](/filings/0001493152-24-045401.md) | [7.7](/filings/0001493152-26-014164.md) | [5.9](/filings/0001641172-25-010572.md) | [4.0](/filings/0001641172-25-023708.md) | [2.5](/filings/0001493152-25-022293.md) | [1.3](/filings/0001493152-26-038399.md) | [0.6](/filings/0001493152-26-023127.md) | [0.4](/filings/0001493152-26-038399.md) |
| Current assets | $m | [7.7](/filings/0001493152-23-040376.md) | [5.8](/filings/0001641172-25-002840.md) | [4.7](/filings/0001493152-24-017176.md) | [3.6](/filings/0001493152-24-030203.md) | [2.4](/filings/0001493152-24-045401.md) | [9.0](/filings/0001493152-26-014164.md) | [7.4](/filings/0001641172-25-010572.md) | [5.5](/filings/0001641172-25-023708.md) | [4.2](/filings/0001493152-25-022293.md) | [2.2](/filings/0001493152-26-038399.md) | [1.5](/filings/0001493152-26-023127.md) | [1.4](/filings/0001493152-26-038399.md) |
| Total assets | $m | [8.0](/filings/0001493152-23-040376.md) | [6.4](/filings/0001641172-25-002840.md) | [5.3](/filings/0001493152-24-017176.md) | [4.2](/filings/0001493152-24-030203.md) | [3.4](/filings/0001493152-24-045401.md) | [9.8](/filings/0001493152-26-014164.md) | [8.2](/filings/0001641172-25-010572.md) | [6.5](/filings/0001641172-25-023708.md) | [5.3](/filings/0001493152-25-022293.md) | [3.3](/filings/0001493152-26-038399.md) | [2.6](/filings/0001493152-26-023127.md) | [2.5](/filings/0001493152-26-038399.md) |
| Current liabilities | $m | [0.4](/filings/0001493152-23-040376.md) | [0.5](/filings/0001641172-25-002840.md) | [0.5](/filings/0001493152-24-017176.md) | [0.5](/filings/0001493152-24-030203.md) | [0.7](/filings/0001493152-24-045401.md) | [14.9](/filings/0001493152-26-014164.md) | [2.0](/filings/0001641172-25-010572.md) | [2.1](/filings/0001641172-25-023708.md) | [2.1](/filings/0001493152-25-022293.md) | [2.3](/filings/0001493152-26-038399.md) | [3.7](/filings/0001493152-26-023127.md) | [4.0](/filings/0001493152-26-038399.md) |
| Total liabilities | $m | [0.4](/filings/0001493152-23-040376.md) | [0.6](/filings/0001641172-25-002840.md) | [0.6](/filings/0001493152-24-017176.md) | [0.6](/filings/0001493152-24-030203.md) | [0.7](/filings/0001493152-24-045401.md) | [15.0](/filings/0001493152-26-014164.md) | [2.0](/filings/0001641172-25-010572.md) | [2.1](/filings/0001641172-25-023708.md) | [2.2](/filings/0001493152-25-022293.md) | [2.4](/filings/0001493152-26-038399.md) | [4.2](/filings/0001493152-26-023127.md) | [6.0](/filings/0001493152-26-038399.md) |
| Shareholders' equity | $m | [7.6](/filings/0001493152-24-045401.md) | [5.8](/filings/0001493152-26-014164.md) | [4.7](/filings/0001641172-25-023708.md) | [3.6](/filings/0001493152-25-022293.md) | [2.6](/filings/0001493152-25-022293.md) | [(5.2)](/filings/0001493152-26-038399.md) | [6.2](/filings/0001493152-26-038399.md) | [4.4](/filings/0001493152-26-038399.md) | [3.1](/filings/0001493152-25-022293.md) | [0.9](/filings/0001493152-26-038399.md) | [(1.5)](/filings/0001493152-26-038399.md) | [(3.5)](/filings/0001493152-26-038399.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,492) d](/filings/0001493152-24-045401.md) | [(1,242) d](/filings/0001641172-25-002840.md) | [(1,151)](/filings/0001641172-25-010572.md) | [(1,190) d](/filings/0001641172-25-023708.md) | [(1,090) d](/filings/0001493152-25-022293.md) | [(1,498) d](/filings/0001493152-26-014164.md) | [(1,564)](/filings/0001493152-26-023127.md) | [(1,213) d](/filings/0001493152-26-038399.md) | [(1,324) d](/filings/0001493152-25-022293.md) | [(1,065) d](/filings/0001493152-26-014164.md) | [(1,095)](/filings/0001493152-26-023127.md) | [(1,720) d](/filings/0001493152-26-038399.md) |
| Capital expenditure | $k | [98.0 d](/filings/0001493152-24-045401.md) | [188 d](/filings/0001641172-25-002840.md) | [83.0](/filings/0001641172-25-010572.md) | [105 d](/filings/0001641172-25-023708.md) | [275 d](/filings/0001493152-25-022293.md) | [39.0 d](/filings/0001493152-26-014164.md) | [131](/filings/0001493152-26-023127.md) | [160 d](/filings/0001493152-26-038399.md) | [93.0 d](/filings/0001493152-25-022293.md) | [85.0 d](/filings/0001493152-26-014164.md) | [87.0](/filings/0001493152-26-023127.md) | [82.0 d](/filings/0001493152-26-038399.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001493152-25-022293.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.8](/filings/0001493152-23-040376.md) | [10.8](/filings/0001493152-24-017176.md) | [1.1](/filings/0001493152-24-030203.md) | [1.3](/filings/0001493152-24-045401.md) | [0.0](/filings/0001641172-25-010572.md) | [1.5](/filings/0001641172-25-023708.md) | [0.0](/filings/0001493152-25-022293.md) | [1.0](/filings/0001493152-26-023127.md) | [4.5](/filings/0001493152-26-038399.md) | [4.6](/filings/0001493152-25-022293.md) | [4.6](/filings/0001493152-26-023127.md) | [4.6](/filings/0001493152-26-038399.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,422,276 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038399.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.